Reviewed Mar 2026 | PubMed sources
Active Market
Netherlands is selected. The evidence comparison is still valid, but provider availability, legal positioning, and cost assumptions may still be staged for later rollout.

Sermorelin vs GHRP-6: Head-to-Head Comparison

Sermorelin provides GHRH-mediated physiological GH release, while GHRP-6 triggers potent ghrelin-mediated pulses with strong appetite stimulation. Sermorelin's former FDA approval gives it a regulatory advantage, but GHRP-6 is one of the most affordable GH secretagogues available.

Approved Comparison Routing

Approved options in this comparison

A
Sermorelin

Sermorelin is currently modeled on this site as an approved treatment path for: Diagnosis and treatment of growth hormone deficiency in children. Brand names in the current dataset: Geref.

Validation note: This block reflects the site's current structured treatment data and internal routing logic. It does not replace checking current labeling, payer rules, or local prescribing conditions.

Want to discuss Sermorelin with a provider?

Sermorelin is currently modeled on this site as an approved treatment path. Use the provider matcher to narrow fit by state, insurance, budget, and urgency.

Join provider rollout

Side-by-Side Comparison

DimensionSermorelinGHRP-6
Evidence LevelFormerly FDA-approvedExtensive preclinical and clinical data
FDA StatusPreviously FDA-approvedNot approved
MechanismGHRH receptor agonistGhrelin receptor agonist
Appetite EffectsNo significant appetite impactVery strong hunger stimulation
Side EffectsFlushing, headacheIntense hunger, dizziness, cortisol/prolactin elevation
CostLow to moderateVery low
GH Release PatternPhysiological, mimics natural GHRHAcute strong pulse via ghrelin pathway
Evidence Level
Sermorelin
Formerly FDA-approved
GHRP-6
Extensive preclinical and clinical data
FDA Status
Sermorelin
Previously FDA-approved
GHRP-6
Not approved
Mechanism
Sermorelin
GHRH receptor agonist
GHRP-6
Ghrelin receptor agonist
Appetite Effects
Sermorelin
No significant appetite impact
GHRP-6
Very strong hunger stimulation
Side Effects
Sermorelin
Flushing, headache
GHRP-6
Intense hunger, dizziness, cortisol/prolactin elevation
Cost
Sermorelin
Low to moderate
GHRP-6
Very low
GH Release Pattern
Sermorelin
Physiological, mimics natural GHRH
GHRP-6
Acute strong pulse via ghrelin pathway

Peptide Overviews

Sermorelin

AFDA Approved

Sermorelin is the shortest fully functional fragment of GHRH (amino acids 1-29). It was the first GHRH analog approved by the FDA, marketed as Geref for diagnostic and therapeutic use. Geref was subsequently discontinued in the U.S. market, though sermorelin remains available through compounding pharmacies. Geref was subsequently discontinued in the U.S. market, though sermorelin remains available through compounding pharmacies.

Growth Hormone SecretagoguesFDA Approved
View full Sermorelin profile →

GHRP-6

BHuman Studies

GHRP-6 was one of the first synthetic GH secretagogues developed. It stimulates strong GH release but also significantly increases appetite through ghrelin receptor activation.

Growth Hormone SecretagoguesNot Approved
View full GHRP-6 profile →

GLP-1 Support Essentials

Products that can support side-effect management, hydration, and protein intake.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Sermorelin vs GHRP-6: FAQ